Skip to content
naulon

No retraction, correction or concern found when last checked on Nov 3, 2026.

Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells

Fan Fan, Shaija Samuel, Kurt W. Evans and 8 more

Cancer Medicine · 2012 · CC BY-NC

doi:10.1002/cam4.4

Abstract

Epithelial–mesenchymal transition ( EMT ) is a critical process providing tumor cells with the ability to migrate and escape from the primary tumor and metastasize to distant sites. Recently, EMT was shown to be associated with the cancer stem cell ( CSC ) phenotype in breast cancer. Snail is a transcription factor that mediates EMT in a number of tumor types, including colorectal cancer ( CRC ). Our study was done to determine the role of Snail in mediating EMT and CSC function in CRC . Human CRC specimens were stained for Snail expression, and human CRC cell lines were transduced with a retroviral Snail construct or vector control. Cell proliferation and chemosensitivity to oxaliplatin of the infected cells were determined by the MTT (colorimetric 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide) assay. Migration and invasion were determined in vitro using modified Boyden chamber assays. EMT and putative CSC markers were analyzed using Western blotting. Intravenous injection of tumor cells was done to evaluate their metastatic potential in mice. Snail was overexpressed in human CRC surgical specimens. This overexpression induced EMT and a CSC ‐like phenotype in human CRC cells and enhanced cell migration and invasion ( P < 0.002 vs. control). Snail overexpression also led to an increase in metastasis formation in vivo ( P < 0.002 vs. control). Furthermore, the Snail‐overexpressing CRC cells were more chemoresistant to oxaliplatin than control cells. Increased Snail expression induces EMT and the CSC ‐like phenotype in CRC cells, which enhance cancer cell invasion and chemoresistance. Thus, Snail is a potential therapeutic target in metastatic CRC .

Shown for reading. Its publisher allows quoting it, not republishing it.

References 41

  1. 1.

    Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006;7:131-142.

    Not in our library10.1038/nrm1835

  2. 2.

    Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 2002;3:155-166.

    Not in our library10.1038/nrm757

  3. 3.

    Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117:927-939.

    Not in our library10.1016/j.cell.2004.06.006

  4. 4.

    Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc. Natl Acad. Sci. USA. 2006;103:18969-18974.

    Not in our library10.1073/pnas.0608636103

  5. 5.

    Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer. 2007;7:415-428.

    Not in our library10.1038/nrc2131

  6. 6.

    Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 2005;8:197-209.

    Not in our library10.1016/j.ccr.2005.07.009

  7. 7.
  8. 8.

    Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, et al. Snail and slug play distinct roles during breast carcinoma progression. Clin. Cancer Res. 2006;12:5395-5402.

    Not in our library10.1158/1078-0432.ccr-06-0478

  9. 9.

    Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK. The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig. Dis. Sci. 2005;50:42-46.

    Not in our library10.1007/s10620-005-1275-z

  10. 10.

    Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631-1643.

    Not in our library10.1002/cncr.20946

  11. 11.

    Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-715.

    Not in our library10.1016/j.cell.2008.03.027

  12. 12.

    Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem. Biophys. Res. Commun. 2009;385:307-313.

    Not in our library10.1016/j.bbrc.2009.05.048

  13. 13.

    Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells. 2009;27:2059-2068.

    Not in our library10.1002/stem.154

  14. 14.

    Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc. Natl Acad. Sci. USA. 1999;96:2316-2321.

    Not in our library10.1073/pnas.96.5.2316

  15. 15.

    Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut. 2001;48:367-371.

    Not in our library10.1136/gut.48.3.367

  16. 16.

    Fan F, Samuel S, Gaur P, Lu J, Dallas NA, Xia L, et al. Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br. J. Cancer. 2011;104:1270-1277.

    Not in our library10.1038/bjc.2011.81

  17. 17.

    Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992;12:4565-4574.

    Not in our library10.1523/jneurosci.12-11-04565.1992

  18. 18.

    Dallas NA, Gray MJ, Xia L, Fan F, Gaur G, van Buren P, et al. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin. Cancer Res. 2008;14:8052-8060.

    Not in our library10.1158/1078-0432.ccr-08-1520

  19. 19.

    Pena C, Garcia JM, Larriba MJ, Barderas R, Gomez I, Herrera M, et al. SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue. Oncogene. 2009;28:4375-4385.

    Not in our library10.1038/onc.2009.285

  20. 20.
  21. 21.

    McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, et al. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J. Clin. Invest. 2009;119:2663-2677.

    Not in our library10.1172/jci37691

  22. 22.

    Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138:645-659.

    Not in our library10.1016/j.cell.2009.06.034

  23. 23.

    Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000;2:84-89.

    Not in our library10.1038/35000034

  24. 24.

    Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004;6:931-940.

    Not in our library10.1038/ncb1173

  25. 25.

    Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871-890.

    Not in our library10.1016/j.cell.2009.11.007

  26. 26.

    Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 2002;161:1881-1891.

    Not in our library10.1016/s0002-9440(10)64464-1

  27. 27.

    Chen WC, Obrink B. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J. Cell Biol. 1991;114:319-327.

    Not in our library10.1083/jcb.114.2.319

  28. 28.

    Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009;119:1420-1428.

    Not in our library10.1172/jci39104

  29. 29.

    Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC, et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology. 2011;141:279-291.

    Not in our library10.1053/j.gastro.2011.04.008

  30. 30.

    Yang AD, Fan F, Camp ER, Liu G, van Buren W, Somcio R, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 2006;12:4147-4153.

    Not in our library10.1158/1078-0432.ccr-06-0038

  31. 31.

    Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res. 2007;67:1979-1987.

    Not in our library10.1158/0008-5472.can-06-1479

  32. 32.

    Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol. 2007;31:277-283.

    Not in our library

  33. 33.

    de Grouw EP, Raaijmakers MH, Boezeman JB, van der Reijden BA, van de Locht LT, de Witte TJ, et al. Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+ CD38− cells. Leukemia. 2006;20:750-754.

    Not in our library10.1038/sj.leu.2404131

  34. 34.
  35. 35.

    Neumeister V, Agarwal J, Bordeaux RL, Rimm DL. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am. J. Pathol. 2010;176:2131-2138.

    Not in our library10.2353/ajpath.2010.090712

  36. 36.

    Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756-760.

    Not in our library10.1038/nature05236

  37. 37.

    Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene. 2008;27:1749-1758.

    Not in our library10.1038/sj.onc.1210811

  38. 38.

    Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 2005;5:275-284.

    Not in our library10.1038/nrc1590

  39. 39.

    Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J. Natl Cancer Inst. 2006;98:1755-1757.

    Not in our library10.1093/jnci/djj505

  40. 40.

    Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007;1:389-402.

    Not in our library10.1016/j.stem.2007.08.001

All 41 references

Cited by papers we hold 5

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.